InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-23.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by West Thomas A., Chairman & CEO. Director active across 4 companies, notably Intersect ENT, Inc.. Aggregated, 11 disclosures have been logged. History available since 23 July 2021. The latest transaction was disclosed on 26 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
8,791 shares0Common StockSEC:0001562180-24-005335:0
18,315 shares0Common StockSEC:0001562180-24-005337:0
21,871 shares0Common StockSEC:0000950170-24-070890:0
17,094 shares0Common StockSEC:0001209191-23-034065:0
1,712 shares0Common StockSEC:0001209191-23-023039:0
6,383 shares0Common StockSEC:0001209191-22-035043:0
39,700 shares@ US$28.2562.6% of flowCommon StockSEC:0001562180-22-004071:0
106,540 shares0Common StockSEC:0001562180-22-001158:0
106,540 shares0Common StockSEC:0001562180-22-001158
19,243 shares@ US$19.743618.7% of flowCommon StockSEC:0001562180-21-005070
19,243 shares@ US$19.743618.7% of flowCommon StockSEC:0001562180-21-005070:0
11 of 11 declarations
About West Thomas A.
Thomas A. West is President and Chief Executive Officer of Intersect ENT, Inc. and Orthofix Medical Inc. In these roles, he is responsible for the strategic and operational leadership of both companies. West implements initiatives aimed at driving growth and enhancing profitability. His leadership and vision are essential for achieving the long-term goals of Intersect ENT and Orthofix.
